Treatment Effects of Xuebijing Injection in Severe Septic Patients with Disseminated Intravascular Coagulation
Table 2
Baseline characteristics of patients.
Control group ()
Intervention group ()
Age (yrs)
56 (49–73)
59 (53–74)
0.14
Male (, %)
51 (61.45)
57 (64.77)
0.652
BMI
0.158
28-day mortality (, %)
29 (34.94)
18 (20.45)
0.034
Platelet (×109/L)
0.326
PT (s)
0.263
Fibrinogen (g/L)
0.17
D-dimer (mg/L)
4.7 (1.85–8.62)
5.2 (2.12–9.53)
0.192
INR
0.607
MEDS score
11 (8–19)
12 (9–21)
0.794
APACHE II score
24 (15–32)
26 (16–35)
0.334
Type of infection (, %)
Pneumonia
39 (46.88)
49 (55.68)
0.256
IAI
37 (44.58)
33 (37.5)
0.347
USI
7 (8.43)
6 (6.82)
0.69
BMI: body mass index; PT: prothrombin time; INR: international normalized ratio; MEDS score: Mortality in Emergency Department Sepsis score; APACHE II score: Acute Physiology and Chronic Health Evaluation II score; IAI: intra-abdominal infection; USI: urinary system infection.